Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
University of Nevada Las Vegas Constructs Science, Engineering and Technology Building
The University of Nevada is building the 205,000-sf Science, Engineering, and Technology (SET) facility at its Las Vegas campus. Construction of the $107-million, four-story facility began in August 2005 and is expected to reach completion in spring of 2008.
Nexus Properties Develops University City Science Center
Nexus Properties is constructing the 141,157-sf University City Science Center in La Jolla, Calif. The two buildings comprise 50,925 sf and 90,232 sf and will accommodate biotechnology and R&D companies. The two-story project was designed by Pacific Cornerstone Architects and is slated for completion in late 2007. Staples Construction Company is the general contractor with CB Richard Ellis as leasing manager.
Commonwealth of Virginia Constructs Center for Behavioral Rehabilitation
The Commonwealth of Virginia is constructing the 96,568-sf Virginia Center for Behavioral Rehabilitation (VCBR) in Burkeville. Built by Gilbane Development Company under a turnkey approach for the Department of Mental Health, Mental Retardation and Substance Abuse Services, the 100-bed VCBR will be the first of its kind in Virginia. A planned expansion will bring an additional 200 beds.
Bristol-Myers Squibb Plans Sale-Leaseback of Princeton Office Space
Bristol-Myers Squibb is putting a total of 900,000 sf of office space in Princeton, N.J., on the market with the intent to establish a long term leaseback. Part of the company's restructuring of its real estate holdings, the facilities to be sold are at two locations. The 77 Scudders Mill road site is comprised of 106 acres with three five-story office buildings connected by an underground service concourse with a multimedia studio. Permits are in place for a fourth five-story office building at the site as well as preliminary approval for two more buildings.
Emergent BioSolutions Dedicates Vaccine Production Plant
Emergent BioSolutions dedicated its 50,000-sf vaccine production plant in Lansing, Mich., on July 21, 2006. The $75-million, three-story facility will enable the company to expand production capacity for its anthrax vaccine, BioThrax®, as well as providing space for future immunobiotics development. Construction on the plant began in February 2006 and is expected to reach completion in early 2007, with FDA certification slated for 2008. The 24/7/365 facility will accommodate 275 employees. Emergent BioSolutions is part of BioPort Corporation.